| Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 |
|---|---|---|---|---|---|---|
Cash flows used in operating activities | ||||||
Net loss | ||||||
-2,791 | -2,419 | -2,664 | -3,328 | -4,582 | -2,705 | -2,814 |
Adjustments for: | ||||||
Stock-based compensation | ||||||
- | 914 | 1,007 | - | - | 1,351 | 1,532 |
Issued stock for commission and option expense | ||||||
28 | 0 | 32 | - | 0 | 0 | 0 |
Convertible note related accretion expense | ||||||
0 | 0 | 0 | 26 | 0 | 93 | 33 |
Changes in non-cash operating balances: | ||||||
Accounts receivable and other receivables | ||||||
10 | -4 | 64 | -81 | 1 | 9 | -6 |
Prepaid expense | ||||||
19 | 7 | -41 | 10 | 10 | 10 | -30 |
Inventories | ||||||
1 | -25 | 1 | 5 | -15 | -4 | 1 |
Accounts payable and accrued liabilities | ||||||
-766 | -383 | -232 | 990 | -148 | -523 | 544 |
Net cash flows used in operating activities | ||||||
-2,371 | -1,910 | -1,833 | -1,269 | -2,428 | -1,769 | -740 |
Cash flows from financing activities | ||||||
Proceeds from issuance of share capital | ||||||
2,000 | 6,100 | 1,832 | 381 | 2,902 | 1,756 | 0 |
Warrants Exercise | ||||||
- | - | - | - | - | - | 354 |
Net cash flows provided by financing activities | ||||||
2,000 | 6,100 | 1,832 | 381 | 2,902 | 1,402 | 354 |
Cash flows used in investing activities | ||||||
Net (decrease) increase in cash | ||||||
-382 | 4,190 | -1 | -888 | 474 | -367 | -386 |